The authors demonstrated that the protein levels of ERβ and its co-activators, TIF2, AIB1 and PELP1, fluctuate as tumor grade increases in astrocytomas and are correlated with clinical and histopathological parameters [37]. The gene discussed is ESR2; the disease is neoplasm.